| Literature DB >> 32253422 |
Kazuya Sakai1, Masataka Kuwana2, Hidenori Tanaka3, Kazuyoshi Hosomichi4, Atsushi Hasegawa5, Hiroki Uyama6, Kenji Nishio7, Takashi Omae8, Masakatsu Hishizawa9, Masashi Matsui10, Koji Iwato11, Akinao Okamoto12, Kazuki Okuhiro13, Yukiko Yamashita14, Masataka Itoh15, Hanae Kumekawa16, Naoki Takezako17, Noriaki Kawano18, Toshihiro Matsukawa19, Haruna Sano20, Kazuiku Ohshiro21, Kunio Hayashi22, Yasunori Ueda23, Toshiki Mushino24, Yoshiyuki Ogawa25, Yuji Yamada26, Mitsuru Murata27, Masanori Matsumoto1.
Abstract
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In white individuals, HLA allele DRB1*11 is a predisposing factor for iTTP, whereas DRB1*04 is a protective factor. However, the role of HLA in Asians is unclear. In this study, we analyzed 10 HLA loci using next-generation sequencing in 52 Japanese patients with iTTP, and the allele frequency in the iTTP group was compared with that in a Japanese control group. We identified the following HLA alleles as predisposing factors for iTTP in the Japanese population: DRB1*08:03 (odds ratio [OR], 3.06; corrected P [Pc] = .005), DRB3/4/5*blank (OR, 2.3; Pc = .007), DQA1*01:03 (OR, 2.25; Pc = .006), and DQB1*06:01 (OR,: 2.41; Pc = .003). The estimated haplotype consisting of these 4 alleles was significantly more frequent in the iTTP group than in the control group (30.8% vs 6.0%; Pc < .001). DRB1*15:01 and DRB5*01:01 were weak protective factors for iTTP (OR, 0.23; Pc = .076; and OR, 0.23, Pc = .034, respectively). On the other hand, DRB1*11 and DRB1*04 were not associated with iTTP in the Japanese. These findings indicated that predisposing and protective factors for iTTP differ between Japanese and white individuals. HLA-DR molecules encoded by DRB1*08:03 and DRB1*11:01 have different peptide-binding motifs, but interestingly, bound to the shared ADAMTS13 peptide in an in silico prediction model.Entities:
Year: 2020 PMID: 32253422 DOI: 10.1182/blood.2020005395
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113